IFN? Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.110495
Publication URI: https://www.repository.cam.ac.uk/handle/1810/371250
Type: Journal Article/Review